Figures & data
Figure 1. Effects of CSP on exhaustive swimming times of mice. Data are expressed as mean ± SD. CSP: polysaccharides from Cordyceps sinensis (Berk.) Sacc.; C: control; LC: low-dose CSP treated (100 mg/kg); IC: intermediate-dose CSP treated (200 mg/kg); HC: high-dose CSP treated (400 mg/kg). *, p < 0.05 compared with C group.
Figure 2. Effects of CSP on SOD activities in serum, liver and muscle of mice. Data are expressed as mean ± SD. CSP: polysaccharides from Cordyceps sinensis; C: control; LC: low-dose CSP treated (100 mg/kg); IC: intermediate-dose CSP treated (200 mg/kg); HC: high-dose CSP treated (400 mg/kg). *, p < 0.05 compared with C group.
Figure 3. Effects of CSP on GPx activities in serum, liver and muscle of mice. Data are expressed as mean ± SD. CSP: polysaccharides from Cordyceps sinensis; C: control; LC: low-dose CSP treated (100 mg/kg); IC: intermediate-dose CSP treated (200 mg/kg); HC: high-dose CSP treated (400 mg/kg). *, p < 0.05 compared with C group.
Figure 4. Effects of CSP on CAT activities in serum, liver and muscle of mice. Data are expressed as mean ± SD. CSP: polysaccharides from Cordyceps sinensis; C: control; LC: low-dose CSP treated (100 mg/kg); IC: intermediate-dose CSP treated (200 mg/kg); HC: high-dose CSP treated (400 mg/kg). *, p < 0.05 compared with C group.
Figure 5. Effects of CSP on MDA levels in serum, liver and muscle of mice. Data are expressed as mean ± SD. CSP: polysaccharides from Cordyceps sinensis; C: control; LC: low-dose CSP treated (100 mg/kg); IC: intermediate-dose CSP treated (200 mg/kg); HC: high-dose CSP treated (400 mg/kg). *, p < 0.05 compared with C group.
Figure 6. Effects of CSP on 8-OHdG levels in serum, liver and muscle of mice. Data are expressed as mean ± SD. CSP: polysaccharides from Cordyceps sinensis; C: control; LC: low-dose CSP treated (100 mg/kg); IC: intermediate-dose CSP treated (200 mg/kg); HC: high-dose CSP treated (400 mg/kg). *, p < 0.05 compared with C group.
